Contraindications: - Personal or family history of medullary thyroid carcinoma (MTC) - Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Serious hypersensitivity to orforglipron Safety profile: Common adverse effects include nausea, diarrhea, constipation, vomiting, abdominal pain, and fatigue
Her discovery of GLP-1 and its critical role in the regulation of insulin secretion and blood glucose led to the development of a revolutionary new class of medicines for type 2 diabetes, obesity, and cardiovascular disease
51 One significant challenge is the high rate of gastrointestinal adverse events associated with these compounds, which may be related to their pharmacokinetic properties and direct gastrointestinal irritation
Diabetes Obes Metab (2017) 19(4):52436
Todays 6,000-word deep-dive (link at the end) is intended to be your one-stop shop for understanding GLP-1s
Cell Microbiol